683 Capital Management’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.08M Buy
6,727,235
+679,615
+11% +$627K 0.16% 91
2025
Q4
$13.3M Buy
6,047,620
+1,397,620
+30% +$2.25M 0.58% 39
2025
Q3
$7.39M Buy
4,650,000
+4,005,000
+621% +$5.2M 0.39% 57
2025
Q2
$1.04M Sell
645,000
-5,000
-0.8% -$8.08K 0.07% 112
2025
Q1
$774K Hold
650,000
0.05% 123
2024
Q4
$1.34M Buy
650,000
+25,000
+4% +$58.2K 0.08% 102
2024
Q3
$1.58M Sell
625,000
-18,000
-3% -$58.7K 0.12% 94
2024
Q2
$2.63M Sell
643,000
-107,000
-14% -$688K 0.2% 81
2024
Q1
$4.72M Buy
+750,000
New +$6.31M 0.35% 58

Other funds holding GUTS

683 Capital Management's GUTS Position: Q1 2026 in Review

683 Capital Management increased its Fractyl Health (GUTS) stake by 11% in Q1 2026, buying an estimated $627K and bringing the position to 6,727,235 shares worth $3.08M. The position accounts for 0.16% of the portfolio, ranked #91.

683 Capital Management first reported a position in GUTS in Q1 2024 and has held it in 9 quarters since. The position peaked at $13.3M in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • 683 Capital Management held 6,727,235 shares of Fractyl Health worth $3.08M as of Q1 2026.
  • 683 Capital Management bought 679,615 Fractyl Health shares in Q1 2026, an estimated $627K.
  • Fractyl Health made up 0.16% of 683 Capital Management's portfolio in Q1 2026, its #91 holding.
  • 683 Capital Management first reported a position in Fractyl Health in Q1 2024 and has held it in 9 quarters since.
  • 683 Capital Management's Fractyl Health position peaked at $13.3M in Q4 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on 683 Capital Management's 13F filing for Q1 2026, filed 15 May 2026.